La Mesa, CA, United States of America

Kassi Kosnicki

This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Kimberly-Clark Worldwide, Inc.. Active years: 2025-2026.

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 2.9

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kassi Kosnicki: Innovator in Metabolite Detection

Introduction

Kassi Kosnicki is a notable inventor based in La Mesa, California. He has made significant contributions to the field of metabolite detection, holding a total of 3 patents. His work focuses on developing methods and consumer products that enhance the understanding of metabolic profiles.

Latest Patents

Kassi's latest patents include innovative methods for detecting various metabolites through urine samples. One patent outlines a method that tests for metabolites such as androstenediol, oxtenedioate, and pregnenetriol, among others. This method aims to produce a comprehensive metabolic profile for the detected metabolites. Another patent similarly focuses on metabolites like ascorbate, dehydroascorbate, and phenylacetylalanine, also producing a metabolic profile for these substances.

Career Highlights

Kassi Kosnicki is currently associated with Kimberly-Clark Worldwide, Inc., where he applies his expertise in metabolite detection. His work has the potential to impact various sectors, including healthcare and consumer products.

Collaborations

Kassi has collaborated with notable coworkers, including Kathleen C Engelbrecht and Stephen Quirk. These partnerships have likely contributed to the advancement of his innovative projects.

Conclusion

Kassi Kosnicki's work in metabolite detection showcases his commitment to innovation and research. His patents reflect a deep understanding of metabolic processes and their implications for health and wellness.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…